0RQE.IL IOB
Idorsia Ltd.
1W: +2.3%
1M: -13.1%
YTD: -26.2%
CHF 4.51 ($5.45)
-0.04 (-0.97%)
Weekly Expected Move ±4.2%
CHF 4
CHF 4
CHF 5
CHF 5
CHF 5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market CapCHF 1.2B ($1.4B)
52W Range2.815-7.55
Volume32,483
Avg Volume288,027
Beta2.47
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJean-Paul Clozel
Employees487
SectorHealthcare
IndustryBiotechnology
IPO Date2017-06-16
Websiteidorsia.com
Hegenheimermattweg 91
Allschwil, BL 4123
CH
Allschwil, BL 4123
CH
41 58 844 10 10
About Idorsia Ltd.
Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and EUCAN. The company was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.
Latest News
No recent news
Recent Insider Trades
No insider trades found